ALX Oncology Holdings Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
35.50
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.77
|
-0.87
|
-0.10
|
-12.99%
|
|
2022-06-30
|
-0.63
|
-0.81
|
-0.18
|
-28.57%
|
|
2022-03-31
|
-0.71
|
-0.60
|
0.11
|
15.49%
|
|
2021-12-31
|
-0.62
|
-0.70
|
-0.08
|
-12.90%
|
|
2021-09-30
|
-0.48
|
-0.61
|
-0.13
|
-27.08%
|
|
2021-06-30
|
-0.43
|
-0.40
|
0.03
|
6.98%
|
|
2021-03-31
|
-0.41
|
-0.35
|
0.06
|
14.63%
|
|
2020-12-31
|
-0.35
|
-0.48
|
-0.13
|
-37.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.28
|
|
2021-12-31
|
-2.06
|
|
2020-12-31
|
-5.50
|